Results 211 to 220 of about 2,121,204 (291)

LOW-RADIOACTIVITY-LEVEL WASTE TREATMENT. PART I. LABORATORY DEVELOPMENT OF A SCAVENGING-PRECIPITATION ION-EXCHANGE PROCESS FOR DECONTAMINATION OF PROCESS WATER WASTES

, 1963
R. R. Holcomb
openalex   +2 more sources

Characteristics of Cerebral Palsy in the Midwestern US

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cerebral palsy (CP) is the most common lifelong motor disability worldwide. Yet, data is limited on how CP manifests in the US. Our objective was to characterize and determine factors affecting functional outcomes in a large population of young people with CP in the Midwestern US.
Susie Kim, Kelsey Steffen, Lauren Gottschalk‐Henneberry, Jennifer Miros, Amy Robichaux‐Viehoever, Karen Taca, Bhooma R. Aravamuthan   +6 more
wiley   +1 more source

Harnessing spent granular activated carbon from point-of-use water treatment for anaerobic digestion enhancement: characterization and pretreatment effects. [PDF]

Bioresour Bioprocess
Kemirembe JB, Ayor A, Kayondo T, Kayiwa R.   +3 more
europepmc   +1 more source

Studies on Water-Treatment. IV. Action of Inorganic Salts on Dilute Aqueous Solutions of Sodium Alkyl Benzene Sulfonate

, 1964
Toshihide Saito, Masanori NAKANE, Masako Hayashi, Goro Kondo, Yoshio Ozasa   +4 more
openalex   +2 more sources

Analysis of Soluble Interleukin‐2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Soluble interleukin‐2 receptor (sIL‐2R) is a biomarker for T cell activity. T cells are involved in neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) pathogenesis. However, sIL‐2R has so far not been evaluated in these conditions.
Philipp Klyscz, Carolin Otto, Klemens Ruprecht, Susanna Asseyer, Hannes Ole Tiedt, Christian Meisel, Judith Bellmann‐Strobl, Friedemann Paul, Patrick Schindler   +8 more
wiley   +1 more source

Optimized Adsorption of Dyes and Antibiotics onto Natural Acacia Ataxacantha for Water Treatment. [PDF]

ACS Omega
Chawraba K, El Malti W, Akil A, Hamieh M, Hammoud M, Patra D, Toufaily J, Hijazi A.   +7 more
europepmc   +1 more source

Exosome Proteomics of SOD1D90A Mutation Suggest Early Disease Mechanisms, and FN1 as a Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease. Super oxide dismutase 1 (SOD1) gene mutations cause ALS, and the D90A mutation is associated with primarily upper motor neuron (UMN) loss. Objective Our goal is to reveal the early cellular events in ALS pathology and identify potential pharmacokinetic biomarkers, using well ...
Mukesh Gautam, Ali Laith, Aslihan Gunel, Melda Yilmaz, Nazli Basak, Halil Idrisoglu, P. Hande Ozdinler   +6 more
wiley   +1 more source

Investigation of water treatment residues as corrosion inhibitors in acidic environment. [PDF]

Sci Rep
Saoudi Hassani EM, Salim R, Ech-Chihbi E, Zejli H, Mehdaoui I, Mahmoud R, Younous YA, A Shazly G, Aqdas A, Taleb A, Taleb M, Rais Z.   +11 more
europepmc   +1 more source

Growth Differentiation Factor 15 Elevation in the Central Nervous System Is Associated With Failure to Thrive in Alexander Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Alexander disease (AxD) is a severe neurodegenerative disorder caused by gain‐of‐function mutations in the gene for GFAP, which lead to protein aggregation and a primary astrocytopathy. Symptoms vary, but failure to thrive (FTT) and frequent emesis are common and cause significant morbidity. Here we investigate GDF15, a member of the
Tracy L. Hagemann, Michelle M. Sonsalla, Cora Luzinski, Fernando Zacahua, David A. Harris, Dudley W. Lamming, Albee Messing   +6 more
wiley   +1 more source

Retraction of "New Smart Magnetic Ionic Liquid Nanocomposites Based on Chemically Bonded Imidazole Silica for Water Treatment". [PDF]

ACS Omega
Sabeela NI, Almutairi TM, Al-Lohedan HA, Ezzat AO, Atta AM.   +4 more
europepmc   +1 more source